Literature DB >> 9916910

The tauopathies: toward an experimental animal model.

M Goedert1, M Hasegawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9916910      PMCID： PMC1853453          DOI： 10.1016/S0002-9440(10)65242-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  59 in total

1.  Primary structure of high molecular weight tau present in the peripheral nervous system.

Authors:  D Couchie; C Mavilia; I S Georgieff; R K Liem; M L Shelanski; J Nunez
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  Structure and novel exons of the human tau gene.

Authors:  A Andreadis; W M Brown; K S Kosik
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

3.  Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.

Authors:  A D Snow; H Mar; D Nochlin; R T Sekiguchi; K Kimata; Y Koike; T N Wight
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

4.  Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system.

Authors:  M Goedert; M G Spillantini; R A Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

5.  Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.

Authors:  M Goedert; M G Spillantini; N J Cairns; R A Crowther
Journal:  Neuron       Date:  1992-01       Impact factor: 17.173

6.  The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease.

Authors:  R A Crowther; O F Olesen; R Jakes; M Goedert
Journal:  FEBS Lett       Date:  1992-09-07       Impact factor: 4.124

7.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

8.  Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.

Authors:  S Flament; A Delacourte; M Verny; J J Hauw; F Javoy-Agid
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Authors:  M Goedert; M G Spillantini; M C Potier; J Ulrich; R A Crowther
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

10.  Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro.

Authors:  H Wille; G Drewes; J Biernat; E M Mandelkow; E Mandelkow
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539
View more
  13 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau protein.

Authors:  Gayathri Ramachandran; Jayant B Udgaonkar
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

3.  Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.

Authors:  H N Dawson; V Cantillana; M Jansen; H Wang; M P Vitek; D M Wilcock; J R Lynch; D T Laskowitz
Journal:  Neuroscience       Date:  2010-04-29       Impact factor: 3.590

4.  Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.

Authors:  Wan Yang; Randall L Woltjer; Izabela Sokal; Catherine Pan; Yan Wang; Mary Brodey; Elaine R Peskind; James B Leverenz; Jing Zhang; Daniel P Perl; Douglas R Galasko; Thomas J Montine
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

Review 5.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

6.  Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice.

Authors:  S Capsoni; G Ugolini; A Comparini; F Ruberti; N Berardi; A Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

7.  Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.

Authors:  A Takeuchi; M C Irizarry; K Duff; T C Saido; K Hsiao Ashe; M Hasegawa; D M Mann; B T Hyman; T Iwatsubo
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 8.  The role of tau in Alzheimer's disease and related disorders.

Authors:  Rodrigo Medeiros; David Baglietto-Vargas; Frank M LaFerla
Journal:  CNS Neurosci Ther       Date:  2010-06-14       Impact factor: 5.243

9.  Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy.

Authors:  Jormay Lim; Martin Balastik; Tae Ho Lee; Kazuhiro Nakamura; Yih-Cherng Liou; Anyang Sun; Greg Finn; Lucia Pastorino; Virginia M-Y Lee; Kun Ping Lu
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

10.  Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.

Authors:  Kiren Ubhi; Edward Rockenstein; Edith Doppler; Michael Mante; Anthony Adame; Christina Patrick; Margarita Trejo; Leslie Crews; Amy Paulino; Herbert Moessler; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2009-02-28       Impact factor: 17.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.